ConditionChronic Mountain Sickness
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThird Military Medical University
About this trial
The study aims to explore the efficacy and safety of erythrocytapheresis in chronic mountain sickness
Eligibility criteria
Qualifiers
Age ≥18 years;
High-altitude residents or long-term dwellers (continuous residence at ≥2500 meters above sea level for at least 1 year), with no travel history to low-altitude areas in the past 3 months;
Hemoglobin (Hb): Men: ≥210 g/L, Women: ≥190 g/L; at least one symptom or sign: headache, dizziness, dyspnea, palpitations, sleep disturbances, fatigue, localized cyanosis, burning sensation in palms/soles, venous dilatation, muscle/joint pain, loss of appetite, poor concentration, or memory changes; CMS total score ≥6;
Written informed consent obtained from patients or their legal representatives.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Erythropheresis
Treatment groups
112 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov